» Topics » Actos | Modern Clinician

Medical News
>
Actos

Latest Actos news

Pioglitazone Has Limited Effect in Lipoatrophic Diabetes

posted September 20th
by modernClinician Editorial Team

Pioglitazone may not be effective for lowering blood glucose levels, although it is associated with slight improvement in liver function, in lipoatrophic diabetes induced by juvenile dermatomyositis, according to a case report published online Sept. 12 in the Journal of Diabetes Investigation.

Greater Benefit for Pioglitazone in High-Risk Patients Post Stroke

posted September 18th
by modernClinician Editorial Team

For patients after an ischemic stroke or transient ischemic attack, pioglitazone is associated with greater benefit for those at higher risk for stroke or myocardial infarction, according to a study published online Sept. 18 in JAMA Neurology.

Exenatide, Pioglitazone Effective for Poorly Controlled T2DM

posted January 23rd
by modernClinician Editorial Team

For patients with long-standing poorly controlled type 2 diabetes mellitus on metformin plus a sulfonylurea, combination therapy with exenatide and pioglitazone is effective and safe, according to a study published online Jan. 17 in Diabetes Care.

Pioglitazone Improves Whole-Body Aerobic Capacity in MetS

posted December 16th
by modernClinician Editorial Team

For adults with metabolic syndrome, pioglitazone treatment improves whole-body aerobic capacity, according to a study published online Dec. 12 in the Journal of Diabetes Investigation.